Target intelligence / Profile preview

Gate control theory of pain (GCT)

Target
GCT
Molecular classification
Other, Neurological mechanism, Sensory processing pathway
01

Overview

The Gate Control Theory of Pain, originally proposed by Melzack and Wall in 1965, describes a physiological mechanism located in the dorsal horn of the spinal cord that modulates the perception of pain (StatPearls, PMID: 31082115). According to this model, a 'gate' exists in the substantia gelatinosa where non-painful sensory input, carried by large-diameter A-beta nerve fibers, activates inhibitory interneurons. These interneurons subsequently inhibit the transmission of pain signals from small-diameter nociceptive fibers (A-delta and C fibers) to the brain, effectively 'closing' the gate to pain (NIH, 2023). This mechanism explains why physical stimuli, such as rubbing an injury, can alleviate the sensation of pain by providing competing non-nociceptive input. While the theory is a functional concept rather than a single molecular target, it is the foundation for numerous clinical interventions, including Transcutaneous Electrical Nerve Stimulation (TENS), spinal cord stimulation (SCS), and various pharmacological strategies aimed at enhancing inhibitory signaling. Modern interpretations of the theory also incorporate descending inhibitory pathways from the periaqueductal gray and medulla that further modulate the spinal gate (PubMed, PMID: 24535357).

Other names
Pain gate mechanismGate control mechanismDorsal horn gatingSpinal gate
02

Mechanism of action

Activation of inhibitory interneurons in the substantia gelatinosa of the spinal cord dorsal horn to suppress the transmission of nociceptive signals from primary afferent neurons to secondary transmission cells.

03

Biological functions

Signal transductionNociception modulationSensory integrationInhibition of pain transmission
04

Disease associations

Chronic painNeuropathic painFibromyalgiaInflammationOther
05

Safety considerations

ParesthesiaTolerance to neurostimulationRisk of masking underlying acute injurySkin irritation from topical or electrical interventions
06

Interacting drugs

Lidocaine

5 more in the full profile.

07

Biomarkers

Visual Analog Scale (VAS)Quantitative Sensory Testing (QST)Pain Pressure Threshold (PPT)Functional MRI (fMRI) of the spinal cord

Beyond the preview

Go deeper on Gate control theory of pain (GCT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gate control theory of pain (GCT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call